<DOC>
	<DOCNO>NCT01327989</DOCNO>
	<brief_summary>The objective study obtain prospective clinical data safety efficacy Solitaire™ FR device patient diagnose acute ischemic stroke .</brief_summary>
	<brief_title>Solitaire FR Thrombectomy Acute Revascularisation</brief_title>
	<detailed_description>The Study multi-center , single-arm , prospective , observational evaluation . The Solitaire™ FR Device certify CE mark . This protocol evaluate safety efficacy Solitaire™ FR Device use routine practice accord Instructions Use .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>1 . Subject subject 's legally authorize representative sign date Informed Consent Form 2 . Age ≥ 18 &lt; 85 3 . Clinical sign consistent acute ischemic stroke 4 . Thrombolysis Cerebral Infarction ( TICI ) 0 TICI 1 flow proximal anterior intracranial vasculature ( M1 M2 Middle Cerebral Artery ( MCA ) , Internal Carotid Artery ( ICA ) intracranial , Internal Carotid Artery ( ICA ) terminal ) 5 . Presentation within 8 hour stroke onset accord local stroke protocol 6 . If stroke presentation within 4.5 hour , one condition meet : Bridging protocol ( start intravenous continue intraarterial ) ( Up maximum 0.9 mg/kg ) Failed intravenous thrombolysis Direct Intraarterial treatment ( accord institution guideline ) 7 . Subject willing conduct followup visit . 8 . National Institutes Health Stroke Scale ( NIHSS ) ≥ 8 ≤ 30 9 . Modified Rankin Scale ( mRS ) ≤ 2 prior stroke onset 1 . Females pregnant lactate 2 . Known serious sensitivity radiographic contrast agent 3 . Neurological sign rapidly improve prior time treatment 4 . Current participation another investigational drug device study 5 . Life expectancy le 90 day 6 . National Institutes Health Stroke Scale ( NIHSS ) &gt; 30 coma 7 . Uncontrolled hypertension define systolic blood pressure &gt; 185 diastolic blood pressure &gt; 110 control except continuous parenteral antihypertensive medication 8 . Use warfarin anticoagulation International Normalised Ratio ( INR ) &gt; 3.0 9 . Platelet count &lt; 30,000 10 . Glucose &lt; 400 mg/dL 11 . Previous stroke within 30 day 12 . Time symptom onset unknown 13 . Seizure onset stroke 14 . Myocardial infarction infection ( sepsis endocarditis ) 15 . Arterial tortuosity would prevent device reach target vessel 16 . Known hypersensitivity nickeltitanium Imaging 17 . Angiographic evidence carotid dissection , complete cervical carotid occlusion , vasculitis 18 . Stenosis proximal thrombus site may preclude safe recovery device 19 . Brain compute tomography ( CT ) sign hemorrhage , arteriovenous venous malformation , aneurysm 20 . Early ischemic change great 1/3 middle cerebral artery ( MCA ) territory accord brain compute tomography ( CT ) Alberta Stroke Program Early CT ( ASPECT ) score ≤ 6 accord magnetic resonance diffusion weight imaging ( MR DWI ) ASPECT score &lt; 5</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Solitaire FR Device</keyword>
	<keyword>Mechanical Thrombectomy</keyword>
	<keyword>Recanalization</keyword>
	<keyword>Brain artery recanalization</keyword>
	<keyword>Neurovascular intervention</keyword>
	<keyword>Interventional Neuroradiology</keyword>
	<keyword>STAR</keyword>
	<keyword>Acute Ischemic Stroke</keyword>
</DOC>